In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
- ENLIVEN, the first placebo-controlled study of a systemic investigational therapy in patients with tenosynovial giant cell tumor (TGCT), enrolled patients where surgery would be associated with potentially worsening functional limitation or severe morbidity.